scispace - formally typeset
H

Helen Varker

Researcher at Truven Health Analytics

Publications -  31
Citations -  1156

Helen Varker is an academic researcher from Truven Health Analytics. The author has contributed to research in topics: Cancer & Warfarin. The author has an hindex of 9, co-authored 29 publications receiving 1048 citations. Previous affiliations of Helen Varker include Thomson Reuters.

Papers
More filters
Journal ArticleDOI

Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

TL;DR: The current prevalence of AF and AFL is high and is projected to increase considerably by 2050, and the current and projected increases in the prevalence are greater than predicted by a previous sentinel study and might reflect more than the aging of the population.
Journal ArticleDOI

Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients

TL;DR: The time course of VTE in medical patients shows that risk of symptomatic VTE is highest during the first 19 days after hospital admission, and extends into the period after discharge, and demonstrates the importance of improving thromboprophylaxis practices in the inpatient setting.
Journal ArticleDOI

Cost burden of second fracture in the US health system.

TL;DR: The average cost of patients with subsequent fracture(s) was substantial and effective management of first fractures may help reduce the long-term economic and clinical burden.
Journal ArticleDOI

Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration

TL;DR: Aflibercept and ranibizumab were used at a similar frequency resulting in similar intravitreal anti-VEGF injection healthcare expenditures among wet age-related macular degeneration patients initiating first-line intrav it real anti-vascular endothelial growth factor treatment.
Journal ArticleDOI

Patterns and Predictors of Use of Warfarin and Other Common Long-Term Medications in Patients with Atrial Fibrillation

TL;DR: Persistence and discontinuation with warfarin in patients with AF is consistent with other long-term medications, while older age, history of ischemic stroke, and war Farfarin use before hospitalization significantly increased warfar in persistence and decreased the likelihood of discontinuation.